PATRICK FOURTEAU Insider Trading $INSY Insys Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PATRICK FOURTEAU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PATRICK FOURTEAU. PATRICK FOURTEAU is Director in REPROS THERAPEUTICS INC. ($RPRX) and President and CEO in REPROS THERAPEUTICS INC. ($RPRX) and CEO and President in SCIELE PHARMA, INC. ($FHRX) and Director in Insys Therapeutics, Inc. ($INSY).
PATRICK FOURTEAU in Insys Therapeutics, Inc.
Trading Symbol: INSYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PATRICK FOURTEAU: Director
Holdings: 69,682 shares
Current Value: $694,033
Latest Transaction: Aug 04 2017
$INSY Market Capitalization: $694.73M
$INSY Previous Close: $9.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PATRICK FOURTEAU in Insys Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, INSY, RPRX, FHRX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 04 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | M | 1.62 | 10,000 | 16,200 | 63,770 | |
Aug 04 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Buy | M | 1.62 | 10,000 | 16,200 | 69,682 | 59.7 K to 69.7 K (+16.76 %) |
May 26 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | M | 3.63 | 10,000 | 36,300 | 50,000 | |
May 26 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Buy | M | 3.63 | 10,000 | 36,300 | 59,682 | 49.7 K to 59.7 K (+20.13 %) |
Feb 23 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
Aug 12 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.46 | 15,000 | 276,900 | 49,682 | 64.7 K to 49.7 K (-23.19 %) |
Aug 12 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.46 | 15,000 | 276,900 | 49,682 | 64.7 K to 49.7 K (-23.19 %) |
May 04 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 14.44 | 25,000 | 361,000 | 25,000 | |
Mar 04 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.22 | 15,000 | 273,300 | 64,682 | 79.7 K to 64.7 K (-18.82 %) |
Nov 13 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 26.48 | 30,000 | 794,400 | 79,682 | 109.7 K to 79.7 K (-27.35 %) |
May 27 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.14 | 1,311 | 78,844 | 54,841 | 56.2 K to 54.8 K (-2.33 %) |
May 27 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 4,784 | 287,040 | 56,152 | 60.9 K to 56.2 K (-7.85 %) |
May 20 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 6,095 | 365,700 | 60,936 | 67 K to 60.9 K (-9.09 %) |
May 20 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 2,969 | 178,140 | 67,031 | 70 K to 67 K (-4.24 %) |
May 07 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
Mar 12 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 59.94 | 10,000 | 599,359 | 70,000 | 80 K to 70 K (-12.50 %) |
Page: 1